Skip to content

Clinical trials

Phase 3 Pulmonary Arterial Hypertension trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 3 Country / region: Israel Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20071
20083
20091
20101
20111
20121
20133
20162
20172
20181
20192
20201
20213
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated7
Active, not recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion8
United Therapeutics8
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Biogen2
Lung Biotechnology PBC2
Aerovate Therapeutics1
Bayer1
Bellerophon Pulse Technologies1
GB002, Inc.1
Gossamer Bio USA, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension31
Hypertension, Pulmonary11
Hypertension5
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3
Lung Diseases3
Respiratory Tract Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Eisenmenger Complex1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.